Journal of Hematology & Oncology

official impact factor 2.93
Search for
Advanced search
Journal of Hematology & Oncology
Tools
Open Access

New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer

Shundong Cang, Yuehua Ma and Delong Liu*

Journal of Hematology & Oncology 2009, 2:22 doi:10.1186/1756-8722-2-22

Accesses  

  • Last 30 days: 117 accesses
  • Last year: 1499 accesses
  • All time: 3828 accesses

Cited by

BioMed Central: 3 citations

Review   Open Access Highly Accessed

Novel agents and regimens for acute myeloid leukemia: 2009 ASH annual meeting highlights

Xiongpeng Zhu, Yuehua Ma, Delong Liu Journal of Hematology & Oncology 2010, 3:17 (23 April 2010)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Letter to the Editor   Open Access

Treatment outcome of thalidomide based regimens in newly diagnosed and relapsed/refractory non-transplant multiple myeloma patients: a single center experience from Thailand

Pimjai Niparuck, Ladda Sorakhunpipitkul, Vichai Atichartakarn, Suporn Chuncharunee, Artit Ungkanont, Pantep Aungchaisuksiri, Teeraya Puavilai, Saengsuree Jootar Journal of Hematology & Oncology 2010, 3:1 (5 January 2010)

Abstract | Full text | PDF | PubMed

Review   Open Access Highly Accessed

Vorinostat in solid and hematologic malignancies

David Siegel, Mohamad Hussein, Chandra Belani, Francisco Robert, Evanthia Galanis, Victoria M Richon, José Garcia-Vargas, Cesar Sanz-Rodriguez, Syed Rizvi Journal of Hematology & Oncology 2009, 2:31 (27 July 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Google Scholar: View citations

PubMed Central: View citations